Peter W. Szlosarek

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, Kotb Abdelmohsen, Akihisa Abe et al. · Autophagy · 2016 · 6K citations · Full text

Life Sciences, Cell Biology, Pathology +9

Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial

Dean A. Fennell, Sean Ewings, Christian H. Ottensmeier et al. · The Lancet Oncology · 2021 · 259 citations · Full text

Medicine, Oncology, Pharmacology +15

Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1–Deficient Malignant Pleural Mesothelioma

Peter W. Szlosarek, Jeremy Steele, Luke Nolan et al. · JAMA Oncology · 2016 · 202 citations · Full text

Medicine, Oncology, Pharmacology +16

<i>In vivo</i> Loss of Expression of Argininosuccinate Synthetase in Malignant Pleural Mesothelioma Is a Biomarker for Susceptibility to Arginine Depletion

Peter W. Szlosarek, Astero Klabatsa, A. Pallaska et al. · Clinical Cancer Research · 2006 · 180 citations

Medicine, Cancer Biology, Oncology +17

Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma

Nelofer Syed, Julia Langer, Karolina Janczar et al. · Cell Death and Disease · 2013 · 169 citations · Full text

Life Sciences, Cancer Biology, Oncology +17